Colicchia, A. and Fabian, D. and Grabenhofer, L. and Grössmann-Waniek, N. and Malíková, E. and Rothschedl, E. and Sehic, O. and Wild, C. and Wolf, S. and Zechmeister-Koss, I. (2025): Fidanacogene elaparvovec (BEQVEZ®) for the treatment of moderately severe to severe haemophilia B. Decision Support Document for the Austrian Appraisal Board 002.

Colicchia, A. and Fabian, D. and Grabenhofer, L. and Geiger-Gritsch, S. and Grössmann-Waniek, N. and Malikova, E. and Rothschedl, E. and Sehic, O. and Wild, C. and Wolf, S. and Zechmeister-Koss, I. (2025): Teprotumumab (TEPEZZA®) for moderate-to-severe thyroid eye disease. Decision Support Document for the Austrian Appraisal Board 003.

Pleyer, J.A. and Hofer, V. and Grabenhofer, L. (2025): Further Development of the Programme on Preventive Health Check-Ups in Austria: Brief interventions for lifestyle counselling Umbrella review and qualitative survey. HTA-Projektbericht 170a.

Grabenhofer, L. and Giess, D. and Pleyer, J.A. and Hofer, V. (2025): Further Development of the Programme on Preventive Medical Check-Ups in Austria. Risk Scores for Cardiovascular Disease: A Systematic Review. HTA-Projektbericht 170b.